Patents by Inventor Kirk Jensen

Kirk Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230337990
    Abstract: Cone-beam computer tomography systems, devices, and methods for image acquisition of large target volumes using partial scans.
    Type: Application
    Filed: June 30, 2023
    Publication date: October 26, 2023
    Inventors: David Kirk JENSEN, Reto W. FILIBERTI, Markus OELHAFEN, Aime Pascal Laurence PAYSAN
  • Patent number: 11737714
    Abstract: Cone-beam computer tomography systems, devices, and methods for image acquisition of large target volumes using partial scans.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: August 29, 2023
    Assignees: VARIAN MEDICAL SYSTEMS, INC., SIEMENS HEALTHINEERS INTERNATIONAL AG
    Inventors: David Kirk Jensen, Reto W. Filiberti, Markus Oelhafen, Aime Pascal Laurence Paysan
  • Publication number: 20210275112
    Abstract: Cone-beam computer tomography systems, devices, and methods for image acquisition of large target volumes using partial scans.
    Type: Application
    Filed: May 18, 2021
    Publication date: September 9, 2021
    Applicants: VARIAN MEDICAL SYSTEMS, INC., VARIAN MEDICAL SYSTEMS INTERNATIONAL AG
    Inventors: David Kirk JENSEN, Reto W. FILIBERTI, Markus OELHAFEN, Aime Pascal Laurence PAYSAN
  • Patent number: 11045151
    Abstract: Cone-beam computer tomography systems, devices, and methods for image acquisition of large target volumes using partial scans.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: June 29, 2021
    Assignees: VARIAN MEDICAL SYSTEMS, INC., VARIAN MEDICAL SYSTEMS INTERNATIONAL AG
    Inventors: David Kirk Jensen, Reto W. Filiberti, Markus Oelhafen, Aime Pascal Laurence Paysan
  • Publication number: 20160278719
    Abstract: Cone-beam computer tomography systems, devices, and methods for image acquisition of large target volumes using partial scans.
    Type: Application
    Filed: November 18, 2013
    Publication date: September 29, 2016
    Inventors: David Kirk JENSEN, Reto W. FILIBERTI, Markus OELHAFEN, Aime Pascal Laurence PAYSAN
  • Patent number: 9447454
    Abstract: The present invention provides methods for purifying RNA molecules interacting with an RNA binding protein (RBP), and the use of such methods to analyze a gene expression profile of a cell. The invention also provides sequences of RNA molecules that mediate binding to an RBP, proteins encoded by the sequences, a method of identifying the sequences, and the use of the sequences in a screen to identify bioactive molecules. The invention also provides RNA motifs found among the sequences and compounds that bind the RNA motifs. In addition, the invention provides methods of treating diseases associated with a function of an RNA binding protein.
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: September 20, 2016
    Assignee: The Rockefeller University
    Inventors: Robert Darnell, Kirk Jensen, Jernej Ule
  • Publication number: 20140378316
    Abstract: The present invention provides methods for purifying RNA molecules interacting with an RNA binding protein (RBP), and the use of such methods to analyze a gene expression profile of a cell. The invention also provides sequences of RNA molecules that mediate binding to an RBP, proteins encoded by the sequences, a method of identifying the sequences, and the use of the sequences in a screen to identify bioactive molecules. The invention also provides RNA motifs found among the sequences and compounds that bind the RNA motifs. In addition, the invention provides methods of treating diseases associated with a function of an RNA binding protein.
    Type: Application
    Filed: December 12, 2013
    Publication date: December 25, 2014
    Applicant: The Rockefeller University
    Inventors: Robert Darnell, Kirk Jensen, Jernej Ule
  • Publication number: 20110076676
    Abstract: The present invention provides methods for purifying RNA molecules interacting with an RNA binding protein (RBP), and the use of such methods to analyze a gene expression profile of a cell. The invention also provides sequences of RNA molecules that mediate binding to an RBP, proteins encoded by the sequences, a method of identifying the sequences, and the use of the sequences in a screen to identify bioactive molecules. The invention also provides RNA motifs found among the sequences and compounds that bind the RNA motifs. In addition, the invention provides methods of treating diseases associated with a function of an RNA binding protein.
    Type: Application
    Filed: July 27, 2009
    Publication date: March 31, 2011
    Applicant: THE ROCKEFELLER UNIVERSITY
    Inventors: Robert Darnell, Kirk Jensen, Jernej Ule
  • Publication number: 20060088877
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Application
    Filed: December 6, 2005
    Publication date: April 27, 2006
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Publication number: 20050227251
    Abstract: The present invention provides methods for purifying RNA molecules interacting with an RNA binding protein (RBP), and the use of such methods to analyze a gene expression profile of a cell. The invention also provides sequences of RNA molecules that mediate binding to an RBP, proteins encoded by the sequences, a method of identifying the sequences, and the use of the sequences in a screen to identify bioactive molecules. The invention also provides RNA motifs found among the sequences and compounds that bind the RNA motifs. In addition, the invention provides methods of treating diseases associated with a function of an RNA binding protein.
    Type: Application
    Filed: October 25, 2004
    Publication date: October 13, 2005
    Inventors: Robert Darnell, Kirk Jensen, Jernej Ule
  • Publication number: 20040132067
    Abstract: A method for identifying nucleic acid ligands to target molecules using the SELEX procedure wherein the candidate nucleic acids contain photoreactive groups and nucleic acid ligands identified thereby are claimed. The complexes of increased affinity nucleic acids and target molecules formed in the procedure are crosslinked by irradiation to facilitate separation from unbound nucleic acids. In other methods partitioning of high and low affinity nucleic acids is facilitated by primer extension steps as shown in the figure in which chain termination nucleotides, digestion resistant nucleotides or nucleotides that allow retention of the cDNA product on an affinity matrix are differentially incorporated into the cDNA products of either the high or low affinity nucleic acids and the cDNA products are treated accordingly to amplification, enzymatic or chemical digestion or by contact with an affinity matrix.
    Type: Application
    Filed: October 8, 2003
    Publication date: July 8, 2004
    Applicant: SOMALOGIC, INC.
    Inventors: Larry Gold, Michael Willis, Tad Koch, Steven Ringquist, Kirk Jensen, Brent Atkinson
  • Publication number: 20030186231
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Application
    Filed: October 9, 2001
    Publication date: October 2, 2003
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Patent number: 6482594
    Abstract: Methods to obtain nucleic acid ligands that photocrosslink to target molecules associated with a disease state are provided. The methods presented are variations on the photoSELEX methods for obtaining nucleic acid ligands. In one method, a candidate mixture of photocrosslinkable nucleic acids is contacted with a biological substance obtained from a source associated with a disease state suspected of containing a target molecule to form nucleic acid-target molecule complexes, the complexes are irradiated to form crosslinked complexes, the photocrosslinked complexes are partitioned from the remainder of the candidate mixture; and the nucleic acid ligands that photocrosslink to molecule are retained. These nucleic acids are then contacted with a second biological substance of the same type as the first, but obtained from a source not associated with a disease state. This removes nucleic acids with affinity to molecules that are not associated with the disease state.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: November 19, 2002
    Assignee: SomaLogic, Inc.
    Inventors: Larry Gold, Michael Willis, Tad Koch, Steven Ringquist, Kirk Jensen, Brent Atkinson
  • Publication number: 20020106652
    Abstract: A method for identifying nucleic acid ligands to target molecules using the SELEX procedure. Nucleic acid candidate sequences contain photoreactive groups. After exposure of the nucleic acid sequences to the target molecule, nucleic acid-target molecule complexes are formed between nucleic acids having increased affinity to the target molecule and the target molecule. The complexes are irradiated such that photocrosslinks form between the photoreactive groups of the bound nucleic acids and the target molecule. The photocrosslinked complexes are separated from unbound nucleic acids, and the nucleic acids amplified to yield a ligand-enriched mixture of nucleic acids.
    Type: Application
    Filed: June 14, 2001
    Publication date: August 8, 2002
    Applicant: SomaLogic, Inc.
    Inventors: Larry Gold, Michael Willis, Tad Koch, Steven Ringquist, Kirk Jensen, Brent Atkinson
  • Patent number: 6300074
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Grant
    Filed: October 4, 1999
    Date of Patent: October 9, 2001
    Assignee: Gilead Sciences, Inc.
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Patent number: 6291184
    Abstract: A method for identifying nucleic acid ligands to target molecules using the SELEX procedure wherein the candidate nucleic acids contain photoreactive groups and nucleic acid ligands identified thereby are claimed. The complexes of increased affinity nucleic acids and target molecules formed in the procedure are crosslinked by irradiation to facilitate separation from unbound nucleic acids. In other methods partitioning of high and low affinity nucleic acids is facilitated by primer extension steps as shown in the figure in which chain termination nucleotides, digestion resistant nucleotides or nucleotides that allow retention of the cDNA product on an affinity matrix are differentially incorporated into the cDNA products of either the high or low affinity nucleic acids and the cDNA products are treated accordingly to amplification, enzymatic or chemical digestion or by contact with an affinity matrix.
    Type: Grant
    Filed: December 13, 1999
    Date of Patent: September 18, 2001
    Assignee: SomaLogic, Inc.
    Inventors: Larry Gold, Michael Willis, Tad Koch, Steven Ringquist, Kirk Jensen, Brent Atkinson
  • Patent number: 6001577
    Abstract: A method for identifying nucleic acid ligands to target molecules using the SELEX procedure wherein the candidate nucleic acids contain photoreactive groups and nucleic acid ligands identified thereby are claimed. The complexes of increased affinity nucleic acids and target molecules formed in the procedure are crosslinked by irradiation to facilitate separation from unbound nucleic acids. In other methods partitioning of high and low affinity nucleic acids is facilitated by primer extension steps as shown in the figure in which chain termination nucleotides, digestion resistant nucleotides or nucleotides that allow retention of the cDNA product on an affinity matrix arc differentially incorporated into the cDNA products of either the high or low affinity nucleic acids and the cDNA products are treated accordingly to amplification, enzymatic or chemical digestion or by contact with an affinity matrix.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: December 14, 1999
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Larry Gold, Michael Willis, Tad Koch, Steven Ringquist, Kirk Jensen, Brent Atkinson
  • Patent number: 5998142
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Grant
    Filed: August 21, 1997
    Date of Patent: December 7, 1999
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Patent number: 5962219
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: October 5, 1999
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Patent number: 5890792
    Abstract: A sun visor or other accessory for a motor vehicle. The sun visor includes a body made of rigid foam in which various structures (such as a support pin, detent and pivot arm) are insert molded. The foam has a rigidity which is sufficient to support said sun visor without requiring any additional reinforcing structures such as a support frame, support wire or centerboard. The pivot arm and detent are provided within a casing that prevents the foam from affecting the operation of the detent. Also insert molded into the body of the visor are mounts for an illuminated vanity. Terminals from a power supply are mounted in predetermined positions relative to the body so that when the vanity is mounted to the body, contacts coupled to a lamp and mounted to the vanity in predetermined positions, are caused engage the terminals.
    Type: Grant
    Filed: May 3, 1996
    Date of Patent: April 6, 1999
    Assignee: Takata, Inc.
    Inventors: Joseph R. Finn, James R. Jones, Kirk Jensen